| scholarly article | Q13442814 |
| P50 | author | Murali M. Yallapu | Q90281357 |
| P2093 | author name string | Santosh Kumar | |
| Theodore J Cory | |||
| Subhash C Chauhan | |||
| Ying Mu | |||
| Elham Hatami | |||
| Deanna N Shields | |||
| P2860 | cites work | The mannose receptor | Q28274841 |
| Influence of the mannose receptor in host immune responses | Q28307450 | ||
| Effect of alpha1-acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro | Q28347042 | ||
| The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
| The role of macrophage polarization in infectious and inflammatory diseases | Q30413135 | ||
| Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype | Q33796715 | ||
| The macrophage in HIV-1 infection: from activation to deactivation? | Q33810779 | ||
| Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production | Q45418471 | ||
| Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers | Q46186910 | ||
| Carbohydrate analysis by a phenol-sulfuric acid method in microplate format | Q46377666 | ||
| Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery | Q46799341 | ||
| Efaverinz and nano-gold-loaded mannosylated niosomes: a host cell-targeted topical HIV-1 prophylaxis via thermogel system | Q47259034 | ||
| Polarized macrophage subsets differentially express the drug efflux transporters MRP1 and BCRP, resulting in altered HIV production | Q47552371 | ||
| Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis | Q49085815 | ||
| Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain. | Q51733190 | ||
| Assembling different antennas of the gp120 high mannose-type glycans on gold nanoparticles provides superior binding to the anti-HIV antibody 2G12 than the individual antennas. | Q53241411 | ||
| Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies. | Q53395698 | ||
| Orchestration of macrophage polarization | Q56942610 | ||
| Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells | Q57070800 | ||
| Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat | Q57420146 | ||
| miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy | Q58702679 | ||
| Surface modified liposomes by mannosylated conjugates anchored via the adamantyl moiety in the lipid bilayer | Q83962424 | ||
| Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART | Q84229162 | ||
| Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes | Q84461047 | ||
| Enhanced drug encapsulation and extended release profiles of calcium-alginate nanoparticles by using tannic acid as a bridging cross-linking agent | Q86030926 | ||
| Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer | Q90952289 | ||
| Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage | Q33864438 | ||
| Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. | Q34025939 | ||
| Intracellular accumulation of human immunodeficiency virus protease inhibitors | Q34143531 | ||
| Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides | Q34203348 | ||
| Long-circulating and target-specific nanoparticles: theory to practice | Q34253450 | ||
| Macrophages and their relevance in Human Immunodeficiency Virus Type I infection | Q34303855 | ||
| Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles | Q35343983 | ||
| Eradication of HIV-1 from the macrophage reservoir: an uncertain goal? | Q35544355 | ||
| Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles | Q35839945 | ||
| Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. | Q35893327 | ||
| Thermo-triggerable self-assembly comprising cinnamoyl polymeric β cyclodextrin and cinnamoyl Pluronic F127. | Q35948629 | ||
| Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets | Q36081148 | ||
| Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence | Q36583170 | ||
| Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice. | Q36603756 | ||
| Macrophages, PPARs, and Cancer | Q36743885 | ||
| Overcoming pharmacologic sanctuaries | Q36915933 | ||
| Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells | Q37003811 | ||
| Macrophage polarization in bacterial infections | Q37259940 | ||
| Macrophage diversity and polarization in atherosclerosis: a question of balance | Q37583322 | ||
| Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics. | Q37659134 | ||
| Macrophage polarization and HIV-1 infection. | Q37665065 | ||
| A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy | Q37692595 | ||
| HIV-1 assembly in macrophages | Q37726306 | ||
| Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection | Q37925515 | ||
| HIV-1 latency in monocytes/macrophages | Q38206643 | ||
| Layer-by-Layer Engineered Microbicide Drug Delivery System Targeting HIV-1 gp120: Physico-Chemical and Biological Properties | Q38613914 | ||
| Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis | Q38840855 | ||
| Recent Advances in Anticancer Activities and Drug Delivery Systems of Tannins | Q39048429 | ||
| Characterization of macrophage activation states in patients with cystic fibrosis | Q39861115 | ||
| Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis. | Q40105242 | ||
| Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. | Q40158060 | ||
| Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas | Q40749683 | ||
| Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions. | Q40750350 | ||
| Effect of tannin-binding agents (polyethylene glycol and polyvinylpyrrolidone) supplementation on in vitro gas production kinetics of some grape yield byproducts | Q40846367 | ||
| Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes | Q41533967 | ||
| Proanthocyanidin: a natural crosslinking reagent for stabilizing collagen matrices | Q42804205 | ||
| Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- mice | Q43177933 | ||
| The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure. | Q43505499 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| macrophage | Q184204 | ||
| P304 | page(s) | 197-207 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Biochemistry and Biophysics Reports | Q27726616 |
| P1476 | title | Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting | |
| P478 | volume | 17 |
| Q91828233 | Optimum Preparation Method for Self-Assembled PEGylation Nano-Adjuvant Based on Rehmannia glutinosa Polysaccharide and Its Immunological Effect on Macrophages |
| Q64904386 | Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery. |
| Q90479600 | Targeting of Hepatic Macrophages by Therapeutic Nanoparticles |
Search more.